Hopes of ending the global HIV epidemic anytime soon are fading among health workers and scientists, who say new infections could increase for the first time in decades.

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

As Obergefell v Hodges turns 10 years, LGBTQ+ rights face renewed threats amid political shifts, impacting health care equity ...

The FDA approved Lenacapavir, the first twice-a-year injection to prevent HIV, marking a historic step in public health.

Tens of thousands of deaths and new HIV infections will be the direct result of Donald Trump’s abandonment of PEPFAR and ...

Tens of millions of people worldwide live with HIV. Lenacapavir can prevent the virus for months with one injection — a ...

Kymera Therapeutics, Inc.'s stock rose on KT-621 data, but Sanofi's exit casts doubts. A Gilead Sciences, Inc. deal offers ...

New York State Assemblymember Zohran Mamdani, 33, shocked political observers with his likely upset of former Gov. Andrew ...

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...